Paper41379264
miR-3613-5p promotes lung cancer progression by targeting and regulating XPO6.
Wang X and 2 others. Discov Oncol, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. miR-3613-5p promotes lung cancer progression by targeting and regulating XPO6. Papers, record 41379264. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41379264
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References42
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33230458 | MicroRNA-3613-5p Promotes Lung Adenocarcinoma Cell Proliferation through a RELA and AKT/MAPK Positive Feedback Loop. | Mol Ther Nucleic Acids | 2020 | https://conductscience.org/library/papers/33230458 | PubMed |
| 2 | 33504342 | Progress on pivotal role and application of exosome in lung cancer carcinogenesis, diagnosis, therapy and prognosis. | Mol Cancer | 2021 | https://conductscience.org/library/papers/33504342 | PubMed |
| 3 | 37879147 | The hsa-miR-3613-5p, a potential oncogene correlated with diagnostic and prognostic merits in kidney renal clear cell carcinoma. | Pathol Res Pract | 2023 | https://conductscience.org/library/papers/37879147 | PubMed |
| 4 | 35095481 | Targeting HSP90 Inhibits Proliferation and Induces Apoptosis Through AKT1/ERK Pathway in Lung Cancer. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/35095481 | PubMed |
| 5 | 21195711 | Reduction of exportin 6 activity leads to actin accumulation via failure of RanGTP restoration and NTF2 sequestration in the nuclei of senescent cells. | Exp Cell Res | 2011 | https://conductscience.org/library/papers/21195711 | PubMed |
| 6 | 33153192 | Prospective Evaluation of Single Nucleotide Variants by Two Different Technologies in Paraffin Samples of Advanced Non-Small Cell Lung Cancer Patients. | Diagnostics (Basel) | 2020 | https://conductscience.org/library/papers/33153192 | PubMed |
| 7 | 33596420 | Cancer-associated exportin-6 upregulation inhibits the transcriptionally repressive and anticancer effects of nuclear profilin-1. | Cell Rep | 2021 | https://conductscience.org/library/papers/33596420 | PubMed |
| 8 | 40326247 | Bioinformatics analyses of potential microRNAs and their target genes in myocardial infarction patients with diabetes. | Diab Vasc Dis Res | 2025 | https://conductscience.org/library/papers/40326247 | PubMed |
| 9 | 27011184 | MicroRNAs as Biomarkers for Diagnosis, Prognosis and Theranostics in Prostate Cancer. | Int J Mol Sci | 2016 | https://conductscience.org/library/papers/27011184 | PubMed |
| 10 | 39776001 | Analysis of exportins expression unveils their prognostic significance in colon adenocarcinoma: insights from public databases. | Discov Oncol | 2025 | https://conductscience.org/library/papers/39776001 | PubMed |
| 11 | 37243787 | Targeting XPO6 inhibits prostate cancer progression and enhances the suppressive efficacy of docetaxel. | Discov Oncol | 2023 | https://conductscience.org/library/papers/37243787 | PubMed |
| 12 | 28591581 | Laminin-111 and the Level of Nuclear Actin Regulate Epithelial Quiescence via Exportin-6. | Cell Rep | 2017 | https://conductscience.org/library/papers/28591581 | PubMed |
| 13 | 40661666 | Editorial: Gastrointestinal damage and metabolic disorders. | Front Physiol | 2025 | https://conductscience.org/library/papers/40661666 | PubMed |
| 14 | 23594563 | Decrease expression of microRNA-20a promotes cancer cell proliferation and predicts poor survival of hepatocellular carcinoma. | J Exp Clin Cancer Res | 2013 | https://conductscience.org/library/papers/23594563 | PubMed |
| 15 | 37611342 | Circulating miR-3613-5p but not miR-125b-5p, miR-199a-3p, and miR-451a are biomarkers of endometriosis. | Reprod Biol | 2023 | https://conductscience.org/library/papers/37611342 | PubMed |
| 16 | 32724419 | Caprin-1 promotes HepG2 cell proliferation, invasion and migration and is associated with poor prognosis in patients with liver cancer. | Oncol Lett | 2020 | https://conductscience.org/library/papers/32724419 | PubMed |
| 17 | 40568772 | COTE1 Regulates AMPKα2 Deubiquitination by Targeting WWP1 Activation to Promote Proliferation and Autophagy in Small Cell Lung Cancer. | J Biochem Mol Toxicol | 2025 | https://conductscience.org/library/papers/40568772 | PubMed |
| 18 | 37490505 | mmu-miRNA-342-3p promotes hepatic stellate cell activation and hepatic fibrosis induced by Echinococcus multilocularis infection via targeting Zbtb7a. | PLoS Negl Trop Dis | 2023 | https://conductscience.org/library/papers/37490505 | PubMed |
| 19 | 29257212 | MicroRNA‑376a inhibits cell proliferation and invasion in glioblastoma multiforme by directly targeting specificity protein 1. | Mol Med Rep | 2018 | https://conductscience.org/library/papers/29257212 | PubMed |
| 20 | 30420640 | A two-miRNA signature (miR-33a-5p and miR-128-3p) in whole blood as potential biomarker for early diagnosis of lung cancer. | Sci Rep | 2018 | https://conductscience.org/library/papers/30420640 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| XPO6 | 23214 | PubTator's text mining | https://conductscience.org/library/genes/23214 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41379264
GET https://conductscience.org/api/papers/v1/41379264/references?page=2